Tuis1099 • HKG
add
Sinopharm Group Co Ltd
Vorige sluiting
$19,80
Dagwisseling
$19,60 - $20,00
Jaarwisseling
$17,44 - $25,20
Markkapitalisasie
61,98 mjd HKD
Gemiddelde volume
6,01 m
P/V-verhouding
6,37
Dividend-opbrengs
4,81%
Primêre beurs
HKG
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(CNY) | Mrt. 2024info | J/J-verandering |
---|---|---|
Inkomste | 147,27 mjd | 1,20% |
Bedryfskoste | 7,19 mjd | 3,80% |
Netto inkomste | 1,42 mjd | -10,70% |
Netto winsgrens | 0,96 | -11,93% |
Wins per aandeel | — | — |
EBITDA | 3,91 mjd | -13,51% |
Effektiewe belastingkoers | 23,21% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(CNY) | Mrt. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 48,91 mjd | 3,62% |
Totale bates | 413,07 mjd | 2,78% |
Totale aanspreeklikheid | 290,20 mjd | 0,49% |
Totale ekwiteit | 122,86 mjd | — |
Uitstaande aandele | 3,12 mjd | — |
Prys om te bespreek | 0,81 | — |
Opbrengs op bates | 2,13% | — |
Opbrengs op kapitaal | 4,25% | — |
Kontantvloei
Netto kontantverandering
(CNY) | Mrt. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 1,42 mjd | -10,70% |
Kontant van bedrywe | -47,48 mjd | -16,68% |
Kontant van beleggings | 256,12 m | -38,43% |
Kontant van finansiering | 22,15 mjd | 4,94% |
Netto kontantverandering | -25,07 mjd | -30,76% |
Beskikbare kontantvloei | -24,53 mjd | -79,75% |
Meer oor
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Gestig
2003
Webwerf
Werknemers
115 959